Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)
17.21
-0.41
(-2.35%)
Streaming Delayed Price
Updated: 11:10 AM EDT, Jun 29, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 1,465,101 |
| Open | 16.97 |
| Bid (Size) | 17.21 (500) |
| Ask (Size) | 17.22 (300) |
| Prev. Close | 17.63 |
| Today's Range | 16.94 - 17.24 |
| 52wk Range | 10.82 - 21.03 |
| Shares Outstanding | 49,471,000 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
What's going on in today's session ↗
March 03, 2026
These stocks are moving in today's session ↗
March 03, 2026
Which stocks are gapping on Tuesday? ↗
March 03, 2026
Irenic Dumps Most Papa John's Shares ↗
February 22, 2026
Frequently Asked Questions
Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
The current price of Theravance Biopharma, Inc. - Ordinary Shares is 17.21
When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 06/29/26 11:10 AM ET
What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 851.64M
How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
Theravance Biopharma, Inc. - Ordinary Shares has 852M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.